DEFA14A ·Filed Mar 19, 2026

GEHC

GE HealthCare Technologies Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001932393-26-000023
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard procedural filing. Traders should monitor for any unexpected developments during the actual shareholder meeting, but no immediate market reaction is expected based on this document.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
GEHC ▼ -7.94% at T+60d
NEUTRAL call ✗ call lost -7.94% · α vs SPY -22.28% · entry $70.35 → $64.76
Entry anchored
Mar 18, 03:59 PM ET
via exchange tick
T+1d
-1.04%
call -1.04% · α +0.70%
$69.62
settled 7mo ago
T+5d
+1.65%
call +1.65% · α +3.86%
$71.51
settled 6mo ago
T+20d
+6.13%
call +6.13% · α -1.49%
$74.66
settled 6mo ago
T+60d
-7.94%
call -7.94% · α -22.28%
$64.76
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

GE HealthCare Technologies Inc. has filed its 2026 Definitive Proxy Statement (DEFA14A), which outlines the agenda for its upcoming annual shareholder meeting. The primary items on the agenda include the election of eight director nominees, an advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor for 2026. This is a routine annual filing with no material financial data or unexpected corporate actions disclosed.

Key Facts

  • The filing is a routine annual proxy statement for the 2026 Annual Meeting.
  • The main agenda items are the election of 8 director nominees, an advisory vote on executive compensation, and the ratification of the independent auditor.
  • No new financial information, strategic changes, or material corporate actions were announced in the filing.

Financial Impact

No immediate financial impact.

Risk Factors

  • The advisory vote on executive compensation could be a point of contention, though it is non-binding.
  • The election of directors is a standard governance matter, but a significant number of votes against a nominee could signal shareholder dissatisfaction.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001932393-26-000023
Document: 0001932393-26-000023-index-headers.html0001932393-26-000023
Document: 0001932393-26-000023-index.html0001932393-26-000023
Document: 0001932393-26-000023.txt0001932393-26-000023
7 reports for GEHC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GEHC — sortable, filterable
TypeNow
Jul 29, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$71.90 $73.31▲ +1.96%▼ −3.06%$63.98 (−11.02%)
May 13, 2026
20w ago
Insider Cluster
NEUTRAL ★ 2/10
$64.26 $61.59▼ −4.16%▼ −4.90%$63.98 (−0.44%)
May 11, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$62.29 $63.76▲ +2.36%▲ +4.09%$63.98 (+2.71%)
Apr 30, 2026
22w ago
Insider Cluster
NEUTRAL ★ 4/10
$60.84 $62.86▲ +3.32%▼ −1.65%$63.98 (+5.16%)
Apr 30, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$60.84 $62.86▲ +3.32%▼ −1.65%$63.98 (+5.16%)
Apr 29, 2026
22w ago
8-K
BEARISH ★ 7/10
$59.49 $63.88▼ −7.39%▼ −1.93%$63.98 (−7.56%)
Mar 19, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$70.35 $74.66▲ +6.13%▼ −1.49%$63.98 (−9.05%)
Showing 7 of 7

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access